Background Prior studies have shown that nutrient excess induces endoplasmic reticulum ( ER ) stress in nonvascular tissues from patients with
diabetes mellitus ( DM ). ER stress and the subsequent unfolded protein response may be protective, but sustained activation may drive
vascular injury. Whether ER stress contributes to endothelial dysfunction in patients with DM remains unknown. Methods and Results To characterize vascular ER stress, we isolated endothelial cells from 42 patients with DM and 37 subjects without DM. Endothelial cells from patients with DM displayed higher levels of ER stress markers compared with controls without DM. Both the early adaptive response, evidenced by higher phosphorylated
protein kinase-like ER eukaryotic initiation factor-2a
kinase and
inositol-requiring ER-to-nucleus signaling
protein 1 ( P=0.02, P=0.007, respectively), and the chronic ER stress response evidenced by higher C/ EBP α-homologous
protein ( P=0.02), were activated in patients with DM . Higher
inositol-requiring ER-to-nucleus signaling
protein 1 activation was associated with lower flow-mediated dilation, consistent with endothelial dysfunction ( r=0.53, P=0.02). Acute treatment with
liraglutide, a
glucagon-like peptide 1 receptor agonist, reduced p-
inositol-requiring ER-to-nucleus signaling
protein 1 ( P=0.01), and the activation of its downstream target
c-jun N-terminal kinase ( P=0.025) in endothelial cells from patients with DM . Furthermore,
liraglutide restored
insulin-stimulated
endothelial nitric oxide synthase activation in patients with DM ( P=0.019). Conclusions In summary, our data suggest that ER stress contributes to vascular
insulin resistance and endothelial dysfunction in patients with DM . Further, we have demonstrated that
liraglutide ameliorates ER stress, decreases
c-jun N-terminal kinase activation and restores
insulin-mediated
endothelial nitric oxide synthase activation in endothelial cells from patients with DM .